Illustration of a clinic building (not a photo of The Center for Cancer and Blood Disorders)
Illustration

Revathi Angitapalli, MD

Hematology/oncology in Weatherford, TX

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • Offers telehealth
  • 26 years since graduation
  • Public record — not managed by the clinician

About Dr. Revathi Angitapalli

Dr. Revathi Angitapalli is a physician specializing in hematology/oncology practicing in Weatherford, TX. Affiliated with Medical City Arlington, Methodist Mansfield Medical Center, Texas Health Arlington Memorial Hospital and 2 more. Treated 381 Medicare patients in 2024.

Provider details

SpecialtyHematology/oncologyOther hematology/oncology doctors in Weatherford
Also practicesInternal Medicine
CredentialsMD
GenderFemale
NPI number1497921829National Provider Identifier (CMS NPPES), issued May 2008
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Dr. Revathi Angitapalli's specialties and state licenses

  • Hematology & Oncology Primary
    License: TX M7828

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Revathi Angitapalli practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Revathi Angitapalli

  • Medical City ArlingtonHospital · Arlington, TX
  • Methodist Mansfield Medical CenterHospital · Mansfield, TX
  • Texas Health Arlington Memorial HospitalHospital · Arlington, TX
  • Usmd Hospital at Arlington L PHospital · Arlington, TX
  • Baylor Scott & White Institute for RehabilitationInpatient rehabilitation facility · Dallas, TX

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Revathi Angitapalli's Medicare quality score (MIPS 2024)

97.8/100final MIPS score
94promoting interoperability
40improvement activities

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Dr. Revathi Angitapalli's Medicare patients and services (2024)

381Medicare patients
176,527services billed
74average patient age
67%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more588$176.20
Injection of additional new drug or substance into vein471$14.59
Administration of chemotherapy into vein, 1 hour or less318$125.13
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more294$123.35
Injection of drug or substance under skin or into muscle191$14.06
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less167$27.10
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less135$58.93
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month103$60.74

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Cancer64%
  • Arthritis49%
  • Diabetes35%
  • Chronic kidney disease30%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Revathi Angitapalli (2025)

$4,276.20 in 142 general payments reported in 2025.

TypePaymentsAmount
Food and beverage128$3,061.67
Long-term medical supply or device loans12$1,098.18
Education2$116.35

Paying companies: NOVARTIS PHARMACEUTICALS CORPORATION ($1,253.34), Celgene Corporation ($316.28), Merck Sharp & Dohme LLC ($249.71), Pfizer Inc. ($239.52), AstraZeneca Pharmaceuticals LP ($155.50), Janssen Biotech, Inc. ($153.61).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at The Center for Cancer and Blood Disorders

Questions about Dr. Revathi Angitapalli

What kind of clinician is Dr. Revathi Angitapalli?

Dr. Revathi Angitapalli is listed as a physician specializing in hematology/oncology, also practicing internal medicine.

Where does Dr. Revathi Angitapalli practice?

The Center for Cancer and Blood Disorders at 920 Santa Fe Dr, Weatherford, TX 76086.

What is the office phone number for Dr. Revathi Angitapalli?

The listed office number is (817) 596-0637. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Revathi Angitapalli?

The National Provider Identifier is 1497921829.

Does Dr. Revathi Angitapalli accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Revathi Angitapalli affiliated with?

Medical City Arlington, Methodist Mansfield Medical Center, Texas Health Arlington Memorial Hospital, Usmd Hospital at Arlington L P, Baylor Scott & White Institute for Rehabilitation.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2025-02-06
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Call The Center for Cancer and Blood Disorders at (817) 596-0637 or visit the clinic page to check availability.

Call now
0 clinics selected Compare